Greenwich LifeSciences
GLSI
#8840
Rank
A$0.32 B
Marketcap
A$22.10
Share price
-2.23%
Change (1 day)
75.44%
Change (1 year)

Greenwich LifeSciences (GLSI) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$8.51 Million

According to Greenwich LifeSciences's latest financial reports the company's total liabilities are A$8.51 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Greenwich LifeSciences - Total liabilities on balance sheet (from 2019 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$8.69 M69.82%
2024-12-31A$5.12 M1085.03%
2023-12-31A$0.43 M11.85%
2022-12-31A$0.38 M-27.28%
2021-12-31A$0.53 M-60.93%
2020-12-31A$1.35 M-30.87%
2019-12-31A$1.96 M-86.45%
2018-12-31A$14.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Organovo
ONVO
A$6.15 M-27.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
A$0.18 B 2,018.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
A$1.69 B 19,802.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
A$0.67 B 7,836.57% Jersey